HLA-DQ2 is a genetic marker strongly associated with celiac disease, an autoimmune condition triggered by gluten that damages the intestinal lining. Testing positive for HLA-DQ2 indicates increased genetic susceptibility, but only 2–5% of carriers develop celiac disease. For general gut health (microbiome, digestion, IBS), HLA-DQ2 alone has little predictive value without clinical symptoms or antibody tests. Many direct-to-consumer tests market HLA-DQ2 as a 'gut health' indicator, which is misleading. Evidence for its utility in asymptomatic individuals is weak; misinterpretation can lead to unnecessary gluten avoidance and nutritional deficiencies. A negative test largely rules out celiac disease but does not assess other gut issues. Conclusion: HLA-DQ2 can aid in celiac disease evaluation, not as a general gut health tool. If you suspect gluten sensitivity, consult a gastroenterologist for proper serology and biopsy.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-36e497588949abd7ec713a2f